Dubai Longevity Authority Launched: Sheikh Hamdan to Lead World's First Regulated Longevity Hub

His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, has issued Law No. (17) of 2026, formally establishing the Dubai Longevity Authority (DLA) — a sovereign regulator mandated to position Dubai as the world''s leading hub for regulated longevity, wellness and advanced healthcare. His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, has been appointed President of DLA, with H.E. Helal Saeed Almarri, Director General of Dubai''s Department of Economy and Tourism, named Chairman.

For clinic investors, life-sciences founders and healthcare operators watching Dubai, this is one of the most consequential regulatory announcements of the decade.

Why the Dubai Longevity Authority matters

The global longevity economy — spanning preventive medicine, regenerative therapies, biotech, precision diagnostics, wellness clinics and healthspan-extending interventions — is projected to exceed USD 600 billion by 2030. Until now, most jurisdictions have regulated these therapies piecemeal, often forcing operators to serve patients under grey-area frameworks. Dubai has just done the opposite: it has built a dedicated, sovereign, science-driven regulator for the entire value chain.

The DLA is mandated to license and supervise:

• Research & development in longevity science, regenerative and cellular medicine
• Clinical trials for advanced therapies and preventive interventions
• Manufacturing of longevity-focused therapeutic products
• Delivery and patient clinics offering these treatments to residents and medical tourists
• Import, distribution and commercialisation of advanced therapeutic products

This end-to-end coverage is exactly what global longevity operators have been asking for: regulatory certainty from lab bench to patient bedside.

A direct pillar of the Dubai Economic Agenda D33

The DLA is explicitly aligned with two of Dubai''s flagship strategies:

• Dubai Economic Agenda D33 — targeting a top-3 global city ranking for quality of life
• Dubai Social Agenda 33 — targeting a global leadership position in healthy life expectancy

DLA will operate in coordination with the Dubai Health Authority (DHA), Dubai Health, Dubai Municipality and Dubai Future Foundation, so existing DHA licensing pathways for clinics, doctors and facilities remain the front door — with the DLA layering a specialised regulatory canopy over longevity-specific therapies that DHA''s general clinical framework was never designed to cover.

"Our ambition is for Dubai to become the world''s leading hub for longevity, wellness and advanced healthcare, and to set new global benchmarks in health and quality of life." — H.H. Sheikh Mohammed bin Rashid Al Maktoum

What this unlocks for healthcare investors in Dubai

H.E. Helal Almarri framed it plainly: DLA is being built as a "sophisticated, sovereign market for advanced therapeutic products and services." For anyone considering clinic setup in Dubai or scaling an existing healthcare business, the practical implications are significant:

• New DHA + DLA licence categories are expected for regenerative medicine, IV wellness, hormone optimisation, peptide therapy, senolytics, gene-based interventions and stem-cell clinics — categories previously navigated case-by-case.
• Foreign longevity groups (US, European, Japanese and Israeli operators) now have a clear regulatory pathway to open patient-facing clinics in Dubai without offshore workarounds.
• Clinical trial capacity in Dubai is expected to expand sharply, giving investors access to a globally rare combination: strong IP protection, world-class hospitals, a fast-track regulator and a diverse patient population.
• Medical tourism — already a AED 12+ billion inbound flow — gets a premium new vertical positioned alongside cosmetic, orthopaedic and fertility tourism.
• Golden Visa eligibility for longevity-specialist doctors, scientists and biotech founders is likely to widen as the sector formalises.

How this changes clinic setup strategy in Dubai

If you were planning a general practice, dermatology, aesthetic, IV wellness or day-surgery clinic in Dubai, the DLA framework should now be part of your feasibility study — not an afterthought. Three shifts we expect over the next 12 months:

1. New sub-specialty licences for longevity, regenerative and preventive medicine will command premium pricing but carry higher scientific and governance requirements.
2. Free-zone operators in DHCC, Dubai South and Expo City will position aggressively to attract longevity R&D and manufacturing tenants — early movers will secure the best terms.
3. Existing wellness and aesthetic clinics will have a clearer pathway to legally add advanced longevity services to their menu, rather than continuing to import them informally.

What clinic investors and operators should do now

The DLA''s executive regulations, licence categories and fee structures will roll out in phases. Investors who wait for full clarity will pay premium entry costs later. Those who engage early — during the framework''s consultation and pilot-licensing phase — will help shape the categories and secure priority slots.

Talk to Dubai''s clinic-setup and DHA licensing specialists

Spectronix Consultancy has been at the front line of clinic setup, DHA licensing, DHCC free-zone structuring, insurance empanelment and Golden Visa pathways for healthcare professionals in Dubai for years. As the Dubai Longevity Authority framework rolls out, our team is already mapping the licensing, compliance and investor-visa implications for our clients.

If you are considering launching a longevity clinic, regenerative medicine centre, IV wellness practice, biotech R&D venture or advanced-therapy facility in Dubai, or you want to understand how the DLA changes your existing clinic''s scope of practice, reach out to us for a confidential consultation. We''ll translate this new regulatory landscape into a practical roadmap for your project.

📞 +971 56 877 1044 📧 spectronixgroup@gmail.com 🔗 Book a free 1-on-1 consultation with Spectronix Consultancy — Dubai''s trusted clinic setup & DHA licensing partner.